Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00844545
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 16
Not applicableStudy completedNCT04757545
What this trial is testing

Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up Care

Who this might be right for
Hematologic Malignancy
Rigshospitalet, Denmark 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862157
What this trial is testing

Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Eosinophilic Leukemia, Not Otherwise Specified+13 more
M.D. Anderson Cancer Center 40
Not applicableLooking for participantsNCT06734637
What this trial is testing

Efficacy and Safety of Peginterferon in ET and PV.

Who this might be right for
Essential ThrombocythemiaPolycythemia Vera
Zhenya Hong 40
Testing effectiveness (Phase 2)Study completedNCT00003239
What this trial is testing

Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 90
Early research (Phase 1)Study completedNCT01830777
What this trial is testing

Brentuximab Vedotin + Re-induction Chemotherapy for AML

Who this might be right for
Acute Myelogenous Leukemia
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)UnknownNCT04877275
What this trial is testing

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Who this might be right for
Multiple Myeloma
Chunyan Sun, MD 50
Early research (Phase 1)Study completedNCT01122875
What this trial is testing

The Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genentech, Inc. 14
Not applicableLooking for participantsNCT05866757
What this trial is testing

Discontinuation Study

Who this might be right for
Multiple MyelomaCancerHematologic Cancer
University College Cork 70
Large-scale testing (Phase 3)Study completedNCT00004112
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Not applicableUnknownNCT02432872
What this trial is testing

Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years

Who this might be right for
Acute Myeloid Leukemia
Jianxiang Wang 300
Testing effectiveness (Phase 2)Ended earlyNCT00210795
What this trial is testing

A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia

Who this might be right for
AnemiaAgedHemoglobins
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 12
Early research (Phase 1)Ended earlyNCT00387153
What this trial is testing

Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer

Who this might be right for
Cancer
Myriad Therapeutics, Inc. 8
Not applicableStudy completedNCT02983253
What this trial is testing

Immunmodulation in Patients With HHT

Who this might be right for
Hereditary Haemorrhagic Telangiectasia (HHT)
University Hospital, Essen 124
Early research (Phase 1)Study completedNCT05376345
What this trial is testing

BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Shanghai Changzheng Hospital 24
Early research (Phase 1)Study completedNCT00060645
What this trial is testing

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 33
Testing effectiveness (Phase 2)Looking for participantsNCT07760454
What this trial is testing

A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
UCARsgen Biotech Limited 68
Not applicableStudy completedNCT01903148
What this trial is testing

Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations

Who this might be right for
ANEMIA
Fundación Senefro 455
Testing effectiveness (Phase 2)Ended earlyNCT04347226
What this trial is testing

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Who this might be right for
Solid TumorSars-CoV2Hematological Malignancy
Columbia University 43
Large-scale testing (Phase 3)Study completedNCT06465485
What this trial is testing

STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

Who this might be right for
Severe Eosinophilic Asthma
AstraZeneca 504
Next Page